162 results
6-K
EX-99.2
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
defined subtotals in the statements of income, as follows: (1) operating profit and (2) profit before financing and tax. In addition, income statement
6-K
EX-99.3
BLRX
Bioline Rx Ltd
28 May 24
BioLineRx Reports First Quarter 2024 Financial Results and Recent Corporate
7:11am
of drug supply issues), for seven years. In addition, Orphan Drug Designation enables sponsors to apply for certain federal grants and tax credits
6-K
EX-10.1
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
the Company nor any Subsidiary is in default with respect to any Indebtedness.
(bb) Tax Status. Except for matters that would not, individually … United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction
6-K
EX-10.2
BLRX
Bioline Rx Ltd
1 Apr 24
BioLineRx Announces $6 Million Registered Direct Offering
10:35am
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto.. Subject to payment
424B5
BLRX
Bioline Rx Ltd
1 Apr 24
Prospectus supplement for primary offering
10:30am
by the Custodian or the Depositary. If the Depositary determines that any distribution in cash or property is subject to any tax or governmental charges … used in currency conversions is available upon request.
Liability of Holders for Taxes, Duties or Other Charges
Any tax or other governmental charge
20-F/A
chjcw5x
26 Mar 24
Annual report (foreign) (amended)
4:57pm
F-3
z1xnv1zc o8b
29 Dec 23
Shelf registration (foreign)
4:15pm
6-K
EX-99
7st0pi
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
o8sr uw00e5qh2st
30 Aug 23
Current report (foreign)
6:45am
6-K
EX-99
yd5qf 1owyovpg7
23 Jun 23
Notice of Annual General Meeting of Shareholders
4:16pm
6-K
EX-10.2
natyjrgfv v9a
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.3
rl7tqh
21 Sep 22
Current report (foreign)
8:00am
6-K
EX-10.1
ir3 mexgepo
21 Sep 22
Current report (foreign)
8:00am
424B5
noo27
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
827mao5qkspy
15 Sep 22
Current report (foreign)
8:39am